Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone® gels

Andrology

Volumn 1, Issue 6, 2013, Pages 899-905

  Roth, M Y ^a   Ilani, N ^b   Wang, C ^b   Page, S T ^a   Bremner, W J ^a   Swerdloff, R S ^b   Dart, C ^c   Sitruk Ware, R ^d   Kumar, N ^d   Blithe, D ^e   Amory, J K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c Health Decisions   (United States)

^d POPULATION COUNCIL   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Contraception; Gonadotropins; Nestorone; Spermatogenesis; Testosterone

Indexed keywords

ELCOMETRINE; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; GEL; GESTAGEN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SPERMATOGENESIS; SPERMATOZOON DENSITY; TESTOSTERONE BLOOD LEVEL;

CONTRACEPTION; GONADOTROPINS; NESTORONE; SPERMATOGENESIS; TESTOSTERONE;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, MALE; FOLLICLE STIMULATING HORMONE; GELS; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; NORPROGESTERONES; SPERMATOGENESIS; TESTOSTERONE;

EID: 84886380709     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/j.2047-2927.2013.00135.x     Document Type: Article

References (27)

1. Amory JK, Anawalt BD, Bremner WJ & Matsumoto AM. (2001) Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development. J Androl 22, 1053-1060.
2. Baker HWG, Santen RJ, Burger HG, De Kretser DM, Hudson B, Pepperell RJ et al. (1975) Rhythms in the secretion of gonadotropins and gonadal steroids. J Steroid Biochem 6, 793-801.
3. Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ & Matsumoto AM. (1996) Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 81, 757-762.
4. Blumenthal PD & Edelman A. (2008) Hormonal contraception. Obstet Gynecol 112, 670-684.
5. Gu YQ, Wang XH, Xu D, Peng L, Cheng LF, Huang MK et al. (2003) A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 88, 562-568.
6. Gu YQ, Tong JS, Ma DZ, Wang XH, Yuan D, Tang WH et al. (2004) Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in Chinese men. J Clin Endocrinol Metab 89, 2254-2262.
7. Gu Y, Liang X, Wu W, Liu M, Song S, Cheng L et al. (2009) Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 94, 1910-1915.
8. Handelsman DJ, Farley TM, Peregoudov A & Waites GM. (1995) Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Fertil Steril 63, 125-133.
9. Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST et al. (2012) A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab 97, 3476-3486.
10. Kamischke A, Ploger D, Venherm S, von Eckardstein S, von Eckardstein A & Nieschlag E. (2000) Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. Clin Endocrinol (Oxf) 53, 43-52.
11. Kamischke A, Heuermann T, Kruger K, von Eckardstein S, Schellschmidt I, Rubig A et al. (2002) An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J Clin Endocrinol Metab 87, 530-539.
12. Liu PY, Swerdloff RS, Anawalt BD, Anderson RA, Bremner WJ, Elliesen J et al. (2008) Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 93, 1774-1783.
13. Matsumoto AM & Bremner WJ. (1984) Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab 58, 609-614.
14. McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD et al. (2004) Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. J Clin Endocrinol Metab 89, 142-149.
15. Mommers E, Kersemaekers WM, Elliesen J, Kepers M, Apter D, Behre HM et al. (2008) Male hormonal contraception: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 93, 2572-2580.
16. Nieschlag E. (2007) 10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception. October 22-23, 2006. Contraception 75, 166-167.
17. Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM et al. (2006) Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab 91, 4374-4380.
18. Page ST, Amory JK & Bremner WJ. (2008) Advances in male contraception. Endocr Rev 29, 465-493.
19. Plymate SR, Tenover JS & Bremner WJ. (1989) Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl 10, 366-371.
20. Rosenberg MJ, Waugh MS & Long S. (1995) Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 40, 355-360.
21. Sedgh G, Henshaw S, Singh S, Ahman E & Shah IH. (2007) Induced abortion: estimated rates and trends worldwide. Lancet 370, 1338-1345.
22. Sitruk-Ware R. (1995) Transdermal application of steroid hormones for contraception. J Steroid Biochem Mol Biol 53, 247-251.
23. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI et al. (2003) Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 88, 4659-4667.
24. Vaughan B, Trussell J, Kost K, Singh S & Jones R. (2008) Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth. Contraception 78, 271-283.
25. World Health Organization (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet 336, 955-959.
26. World Health Organization (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65, 821-829.
27. World Health Organization (2010) World Health Organization Laboratory Manual for the Examination and Processing of Human Semen, 5th edn. World Health Organization, Geneva, Swtizerland.